News Human Genome Sciences Reports Progress with Commercialization of BENLYSTA(R) and Announces 2012 Goals at JPMorgan Healthcare Conference – MarketWatch Steady progress toward broader adoption of BENLYSTA treatment Human Genome Sciences, Inc. HGSI +1.18% will today announce its priority goals…adminJanuary 9, 2012
